Cytokinetics, Incorporated CYTK

64.66 (1.00) (1.52%) as of 25 Sep
Market cap
$9.0B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
156.25 268.89 198.73 225.11 464.06 471.64 782.58 614.82 1,076.01 882.22
Receivables
0.02 1.11 2.23 5.16 4.42 51.82 0.15 1.28 16.65 17.76
Other current assets
2.16 4.29 4.55 3.00 6.00 12.00 12.00 13.23 — —
Total current assets
158.63 274.30 207.67 233.75 474.22 535.67 795.19 628.05 1,107.94 916.98
Property, Plant, Equpment (Net)
3.64 3.57 3.20 4.53 13.35 73.27 80.45 68.75 65.82 79.19
Long-Term Investments
7.67 16.52 — 42.65 36.95 152.05 46.71 40.53 145.06 335.05
Long-term assets (Other)
0.20 0.43 0.00 9.00 6.36 7.19 9.69 8.00 7.71 17.34
Total non-current assets
11.51 20.52 3.50 56.06 59.58 305.65 219.59 196.27 293.73 507.56
Total Assets
170.14 294.81 211.18 289.81 533.80 841.32 1,014.78 824.32 1,401.67 1,424.54
Accounts Payable
4.24 5.25 3.76 8.16 8.05 21.09 25.61 21.51 20.37 22.34
Accrued Expenses
18.05 17.39 15.76 12.12 19.32 34.37 44.10 42.64 55.32 83.28
Current Part of Debt
2.50 — 2.61 5.00 3.00 15.00 0.96 10.08 11.52 41.18
Current Revenue (Deferred)
8.06 9.57 — — — — — — 52.37 1.61
Other current liabilities
0.42 0.23 0.07 1.12 1.05 1.54 1.12 10.56 21.11 34.93
Total current liabilities
33.26 32.44 22.19 26.02 31.20 71.86 84.62 102.68 179.67 202.45
Long Term Debt (Total)
27.38 31.78 39.81 129.26 135.71 142.84 609.62 607.37 645.60 1,115.98
Non-current Revenue (Deferred)
15.00 15.00 — — 87.00 87.00 — — — —
Non-current Liabilities (Other)
0.14 105.75 122.47 143.28 166.07 183.53 301.55 380.16 599.19 657.76
Total non-current liabilities
42.52 152.52 163.05 274.73 389.22 525.60 1,038.06 1,107.96 1,357.37 1,881.71
Total liabilities
75.78 184.97 185.24 300.75 420.42 597.46 1,122.68 1,210.64 1,537.05 2,084.16
Additional Paid In Capital
612.47 755.53 768.70 853.34 1,105.47 1,452.27 1,481.59 1,725.82 2,563.88 2,826.34
Common Stock (Net)
0.04 0.05 0.06 0.06 0.07 0.08 0.09 0.10 0.12 0.12
Retained Earnings
(518.29) (646.08) (743.32) (865.02) (992.31) (1,207.62) (1,585.99) (2,112.24) (2,701.76) (3,486.72)
Common Equity (Total)
94.36 109.84 25.93 (10.94) 113.38 243.86 (107.90) (386.32) (135.37) (659.62)
Shareholders Equity (Total)
94.36 109.84 25.93 (10.94) 113.38 243.86 (107.90) (386.32) (135.37) (659.62)
Shareholders Equity and Liabilities (Total)
170.14 294.81 211.18 289.81 533.80 841.32 1,014.78 824.32 1,401.67 1,424.54
Shares (Common)
40.65 53.96 54.72 59.17 71.02 84.80 94.83 101.64 118.21 122.94
Shareholders Equity (Tangible)
94.36 109.84 25.93 (10.94) 113.38 243.86 (107.90) (386.32) (135.37) (659.63)
Net Debt
(126.37) (237.11) (156.32) (90.85) (325.35) (313.80) (172.00) 2.63 (418.90) 274.94
Total Debt
29.88 31.78 42.41 134.26 138.71 157.84 610.58 617.45 657.12 1,157.16

Fold the line items

In millions of $ except per-share values · columns are period end dates